Express News | Adaptimmune Therapeutics PLC : Jonestrading Raises Target Price to $2.50 From $2

Reuters00:37 ET

JonesTrading Maintains Adaptimmune Therapeutics(ADAP.US) With Buy Rating, Raises Target Price to $2.5

JonesTrading analyst Soumit Roy maintains $Adaptimmune Therapeutics(ADAP.US)$ with a buy rating, and adjusts the target price from $2 to $2.5.According to TipRanks data, the analyst has a success

Moomoo NewsJul 19 14:31 ET · Ratings

European Equities Traded in the US as American Depositary Receipts Trend Lower Thursday

European equities traded in the US as American depositary receipts were moving moderately lower late Thursday morning, declining 0.72% to 1,423.26 on the S&P Europe Select ADR Index.From continental

MT NewswiresJul 18 11:08 ET

European Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading

European equities traded in the US as American depositary receipts opened the week trending lower late Monday morning, declining 0.37% to 1,463.52 on the S&P Europe Select ADR Index.From continental

MT NewswiresJul 15 11:15 ET

European Equities Traded in the US as American Depositary Receipts Rise Slightly in Thursday Trading

European equities traded in the US as American depositary receipts were trending slightly higher late Thursday morning, rising 0.19% to 1,460.27 on the S&P Europe Select ADR Index.From continental

MT NewswiresJul 11 11:17 ET

European Equities Traded in the US as American Depositary Receipts Flat in Monday Trading

European equities traded in the US as American depositary receipts started the week off on a flat note late Monday morning, nudging 0.002% higher to 1,452.10 on the S&P Europe Select ADR Index.From co

MT NewswiresJul 8 11:13 ET